Amorfix, Pan-Provincial Vaccine Enterprise Inc. deal

The not-for-profit PREVENT received exclusive, worldwide rights to Amorfix's preclinical vaccines to treat and prevent amyotrophic lateral sclerosis (ALS). PREVENT will conduct Phase I testing at its ...